The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical value of event-free survival (EFS) in acute myeloid leukemia (AML).
 
Abhishek Maiti
Research Funding - Celgene (Inst)
 
Hagop M. Kantarjian
Honoraria - Abbvie; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer
Research Funding - Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Vinita Popat
No Relationships to Disclose
 
Carlos Blanco
No Relationships to Disclose
 
Miguel Velasquez
No Relationships to Disclose
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Celgene; Helsinn Healthcare
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Celgene; Jazz Pharmaceuticals
Research Funding - Astex Pharmaceuticals; celgene
 
Marina Konopleva
Stock and Other Ownership Interests - Reata Pharmaceuticals
Honoraria - Abbvie; Calithera Biosciences; Genentech
Consulting or Advisory Role - AbbVie; Cellectis; Genentech/Roche; Stemline Therapeutics
Research Funding - Abbvie (Inst); Ablynx (Inst); Calithera Biosciences (Inst); Cellectis (Inst); Genentech (Inst); Lilly (Inst); Roche (Inst); Stemline Therapeutics (Inst)
 
Srdan Verstovsek
Consulting or Advisory Role - Celgene; Constellation Pharmaceuticals; Incyte; Novartis; Pragmatist; Sierra Oncology
Research Funding - Blueprint Medicines; Celgene; CTI BioPharma Corp; Genentech; Gilead Sciences; Incyte; Novartis; NS Pharma; Promedior; Roche
 
Michael Andreeff
Stock and Other Ownership Interests - Aptose Biosciences; Eutropics; Oncoceutics; Oncolyze; Reata Pharmaceuticals; Senti Biosciences
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals
Research Funding - Amgen; AstraZeneca; Breast Cancer Research Foundation; CPRIT; Daiichi Sankyo; Karyopharm Therapeutics; NIH/NCI; Ono Pharmaceutical; United Therapeutics
Patents, Royalties, Other Intellectual Property - Patent with Reata
Travel, Accommodations, Expenses - Amgen; Aptose Biosciences; AstraZeneca; Oncoceutics
 
Gautam Borthakur
No Relationships to Disclose
 
Tapan M. Kadia
Consulting or Advisory Role - Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Celgene; Sanofi
 
Naval Guastad Daver
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Immunogen; Nohla Therapeutics; Pfizer; Servier
 
Naveen Pemmaraju
Honoraria - Celgene; Incyte; LFB Biotechnologies; Novartis; Stemline Therapeutics
Consulting or Advisory Role - Celgene; Incyte; LFB Biotechnologies; Novartis; Stemline Therapeutics
Research Funding - Abbvie; Affymetrix/Thermo Fisher Scientific; Cellectis; Daiichi Sankyo; Incyte; Novartis; Plexxikon; Samus Therapeutics; Stemline Therapeutics
Travel, Accommodations, Expenses - Celgene; mustangbio; Stemline Therapeutics
 
Courtney Denton Dinardo
Honoraria - Abbvie; Agios; Bayer; Celgene; Karyopharm Therapeutics; MedImmune
Consulting or Advisory Role - Agios; Celgene
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo
 
Sherry A. Pierce
No Relationships to Disclose
 
William G. Wierda
Consulting or Advisory Role - Sanofi
Research Funding - Abbvie; Acerta Pharma; Cyclacel; Emergent BioSolutions; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Loxo; miRagen; Oncternal Therapeutics, Inc; Pharmacyclics; Sunesis Pharmaceuticals; Xencor
 
Steven Mitchell Kornblau
No Relationships to Disclose
 
Farhad Ravandi
No Relationships to Disclose
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Takeda
Research Funding - Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)